Company / Free Cash Flow per Share
VYNE Therapeutics Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.30
FY2025
5-year range
-$3.18 / -$1.80
FY2021-FY2025
Trend
-27.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-3.18 to $-2.30 over the past 4 years.
Based on SEC 10-K filings.
-2.30 in FY2025.
Improved from $-3.18 to $-2.30 over the past 4 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 27.9% year-over-year.
- Peak free cash flow per share was recorded in FY2018.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.30 | -27.9% |
| FY2024 | -$1.80 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$3.18 | +58.2% |
| FY2020 | -$7.59 | -524.3% |
| FY2019 | -$1.22 | -180.6% |
| FY2018 | -$0.43 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026